C-peptide and its intracellular signaling

Review of Diabetic Studies

Volumn 6, Issue 3, 2009, Pages 138-147

  Hills, Claire E ^a   Brunskill, Nigel J ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

C peptide; Diabetes; Kidney; Nephropathy; NF kappaB; Nitric oxide; p38 MAPK; PPAR; Protein kinase; Receptor; TGF beta1; TNF alpha; VACM 1

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); C PEPTIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR;

BINDING SITE; CELL GROWTH; CELL MIGRATION; CELL PROTECTION; CELL SURVIVAL; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN LIKE ACTIVITY; KIDNEY TUBULE CELL; MEDIATOR RELEASE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 76149123913     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2009.6.138     Document Type: Review

References (58)

1. Wald HP, Scherzer P, Rasch R, Popovtzer MM. Renal tubular Na+,K+-ATPase in diabetes mellitus: relationship to metabolic abnormality. Am J Physiol 1993. 265(1 Pt 1):E96-E101.
2. Raccah D, Lamotte-Jannot MF, Issautier T, Vague P. Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney. Diabete Metab 1994. 20(3):271-274.
3. Raccah D, Lamotte-Jannot MF, Issautier T, Vague P. Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients. Diabetes Care 1996. 19:564-568.
4. Gerbi A, Barbey O, Raccah D, Coste T, Jamme I, Nouvelot A, Ouafik L, Levy S, Vague P, Maixment JM. Alteration of Na, K-ATPase isoenzymes in diabetic cardiomyopathy: effect of dietary supplementation with fish oil (n-3 fatty acids) in rats. Diabetologia 1997. 40:496-505.
5. +-ATPase activity in synergism with neuropeptide Y. Diabetologia 1996. 39:199-205.
6. Dufayet De La Tour D, Raccah D, Jannot MF, Coste T, Rougerie C, Vague P. Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level. Diabetologia 1998. 41:1080-1084.
7. Forst T, Dufayet De La Tour D, Kunt T, Pfutzner A, Goitom K, Pohlmann T, Schneider S, Johansson BL, Wahren J, Lobig M, Engelbach M, Beyer J, Vague P. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+, K+-ATPase activity in diabetes mellitus type. Clin Sci 2000. 98:283-290.
8. Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF, DiMarchi RD, Di Cera E, Williamson JR. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997. 277:563-566.
9. Tsimaratos M, Roger F, Chabardes D, Mordasini D, Hasler U, Doucet A, Martin PY, Feraille E. C-peptide stimulates Na+, K+-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 2003. 46:124-131.
10. Maestroni A, Ruggieri D, Dell'Antonio G, Luzi L, Zerbini G. C-peptide increases the expression of vaso pressin-activated calcium-mobilizing receptor gene through a G protein-dependent pathway. Eur J Endocrinol 2005. 152:135-141.
11. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, Rigler R, Jörnvall H. Role of C-peptide in human physiology. Am J Physiol 2000. 278:E759-E768.
12. Li L, Oshida Y, Kusunoki M, Yamanouchi K, Johansson BL, Wahren J, Sato Y. Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats. Diabetologia 1999. 42:958-964.
13. Etgen GJ, Fryburg DA, Gibbs EM. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylininositol-3 kinase-independent pathway. Diabetes 1997. 46:1915-1919.
14. Young ME, Radda GK, Leighton B. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem J 1997. 322:223-228.
15. Jensen ME, Messina EJ. C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin. Am J Physiol 1999. 276:H1223-H1228.
16. Joshua IG, Zhang Q, Falcone JC, Bratcher AP, Rodriguez WE, Tyagi SC. Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide. J Cell Biochem . 96:1149-1156.
17. Wallerath T, Kunt T, Forst T, Closs EI, Lehmann R, Flohr T, Gabriel M, Schäfer D, Göpfert A, Pfützner A, Beyer J, Förstermann U. Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 2003. 9:95-102.
18. Kitamura T, Kimura K, Makondo K, Furuya DT, Suzuki M, Yoshida T, Saito M. Proinsulin C peptide increases nitric oxide production by enhancing mitogenactivated protein-kinase dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. Diabetologia 2003. 46:1698-1705.
19. Scalia R, Coyle K, Levine B, Booth G, Lefer A. C peptide inhibits leukocyte-enodthelium interaction in the microcirculation during endothelial dysfunction. FASEB J 2000. 14:2357-2364.
20. Chang L, Karin. Mammalian MAP kinase signaling cascades. Nature 2000. 410:37-40.
21. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH. MAP kinases. Chem Rev 2001. 101:2449-2476.
22. Turjanski AG, Vaque JP, Gutkin JS. MAP kinases and the control of nuclear events. Oncogene 2007. 26:3240-3253.
23. Kitamura T, Kimura K, Jung BD, Makondo K, Okamoto S, Canas X, Sakane N, Yoshida T, Saito M. Proinsulin C peptide rapidly stimulates mitogen activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein phosphoinositide 3-kinase and pertussi toxin-sensitive G protein. Biochem J 2001. 355:123-129.
24. Kitamura T, Kimura K, Jung BD, Makondon K, Sakane N, Yoshida T, Saito M. Proinsulin C peptide activates cAMP response element binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J 2002. 366:737-744.
25. Al-Rasheed NM, Meakin F, Royal EL, Lewington AJ, Brown J, Willars GB, Brunskill NJ. Potent activation of multiple signaling pathways by C peptide in opossum kidney proximal tubular cells. Diabetologia 2004. 47:987-997.
26. Zhong Z, Davidescu A, Ehren I, Ekberg K, Jornvall H, Wahren J, Chibalin AV. C peptide stimulates ERK 1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells. Diabetologia 2005. 48:187-197.
27. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD. Synthesis and function of 3-phosphorylated inositol lipids. Ann Rev Biochem 2001. 70:535-602.
28. Li ZG, Zhang W, Sima AA. C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells. Diabetes Metab Res Rev 2003. 19:375-385.
29. Walcher D, Aleksic M, Jerg V, Hombach V, Zieske A, Homma S, Strong J, Marx N. C-peptide induces chemotaxis of human CD4-positive cells. Involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes 2004. 53:1664-1670.
30. Grunberger G, Qiang X, Li Z, Mathews S, Sbrissa D, Shisheva A, Sima AA. Molecular basis for the insulinometric effects of C peptide. Diabetologia 2001. 44:1247-1257.
31. Aleksic M, Walcher D, Giehl K, Bach H, Grub M, Durst R, Hombach V, Marx N. Signaling processes involved in C-peptide induced chemotaxis of CD4-positive lymphocytes. Cell Mol Life Sci 2009. 66:1974-1984.
32. Al-Rasheed NM, Chana RS, Baines RJ, Willars GB, Brunskill NJ. Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity. J Biol Chem 2004. 279:49747-49754.
33. Kitazawa M, Shibata Y, Hashimoto S, Ohizumi Y, Yamakuni T. Proinsulin C-peptide stimulates a PKC/IkappaB/NFkappaB signaling pathway to activate COX-1 gene transcription in Swiss 3T3 fibroblasts. J Biochem 2006. 139:1083-1088.
34. Al Rasheed NM, Willars GB, Brunskill NJ. C-peptide signals via Galphai to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells. J Am Soc Nephrol 2006. 17:986-995.
35. Willson TM, Lambert MH, Kliewer SA. Peroxisome proliferator-activated receptor-gamma and metabolic disease. Annu Rev Biochem 2001. 70:341-367.
36. Rieusset J, Andreelli F, Auboeuf D, Roques M, Vallier P, Riou JP, Auwerx J, Laville M, Vidal H. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes 1999. 48:699-705.
37. Kalantarinia K, Awad AS, Siragy HM. Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats. Kidney Int 2003. 64:1208-1213.
38. Moriwaki Y, Yamamoto T, Shibutani Y, Aoki E, Tustsumi Z, Takahashi S, Okamura H, Koga M, Fukuchi M, Hada T. Elevated level of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 2003. 52:605-608.
39. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003. 10:45-65.
40. Baud L, Oudinet JP, Bens M, Noel L, Peraldi MN, Rondeau E, Etienne J, Ardaillou R. Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 1989. 35:1111-1118.
41. Hruby ZW, Lowry RP. Spontaneous release of tumor necrosis factor alpha by isolated renal glomeruli and cultured glomerular mesangial cells. Clin Immunol Immunopathol 1991. 59:156-164.
42. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 2008. 233:4-11.
43. Sharma K, Ziyadeh FN. Hyperglycaemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995. 44:1139-1146.
44. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001. 108:1853-1863.
45. Qi W, Chen X, Zhang Y, Waltham M, Schache M, Kelly DJ, Pollock CA. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism. Nephrol Dial Transplant 2007. 11:3147-3153.
46. Tian YC, Fraser D, Attisano L, Philips AO. TGF-beta 1 mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol 2003. 285:F130-F142.
47. Humes HD, Nakamura T, Cieslinski DA, Miller D, Emmons RV, Border WA. Role of proteoglycans and cytoskeleton in the effects of TGF-beta 1 on renal proximal tubule cells. Kidney Int 1993. 43:575-584.
48. Hills CE, Al-Rasheed N, Al-Rasheed N, Willars GB, Brunskill NJ. C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am J Physiol 2009. 296:F614-621.
49. Flatt PR, Swanston-Flatt SK, Hampton SM, Bailey CJ, Marks V. Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor. Biosci Rep 1986. 6:193-199.
50. Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson O, Nygren PA, Stahl S, Ekberg K, Johansson BL, Uhlen S, Uhlen M, Jornvall H, Wahren J. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 1999. 96:13318-13323.
51. Henriksson M, Nordling E, Melles E, Shafqat J, Ståhlberg M, Ekberg K, Persson B, Bergman T, Wahren J, Johansson J, Jörnvall H. Separate functional features of proinsulin C-peptide. Cell Mol Life Sci 2005. 62:1772-1778.
52. Zierath JR, Handberg A, Tally M, Wallberg-Henriksson H. C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia 1996. 39:306-313.
53. Henriksson M, Johansson J, Moede T, Leibiger I, Shafqat J, Berggren P, Jörnvall H. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in interpeptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling. Cell Mol Life Sci 2006. 63:3055-3060.
54. Gschwind A, Zwick E, Prenzel N, Leserer M, Ullrich A. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 2001. 20:1594-1600.
55. Rao GN, Delafontaine P, Runge MS. Thrombin Stimulates Phosphorylation of Insulin-like Growth Factor-1 Receptor, Insulin Receptor Substrate-1, and Phospholipase C-1 in Rat Aortic Smooth Muscle Cells. J Biol Chem 1995. 270:27871-27875.
56. Luzi, L, Zerbini G, Caumo A. C-peptide: a redundant relative of insulin? Diabetologia 2007. 50:500-502.
57. Medawala W, McCahill P, Giebink A, Meyer J, Ku CJ, Spence DM. A molecular level understanding of zinc activation of C-peptide and its effects on cellular communication in the bloodstream. Rev Diabet Stud 2009. This issue.
58. Meyer JA, Froelich JM, Reid GE, Karunarathne WK, Spence DM. Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. Diabetologia 2008. 51:175-182.